Abstract
Infection with Mycobacterium tuberculosis (MTB) is accompanied by an intense local inflammatory response which may be critical to the pathogenesis of tuberculosis. Activation of components of the innate immune response, such as recruitment of polymorphonuclear (PMN) and mononuclear phagocytes and induction of pro-inflammatory cytokines, such as tumor necrosis factor α (TNF-α), by MTB occurs early after MTB infection, however, may persist as the organism establishes itself within granulomas. MTB and its protein and non-protein components are potent in induction of cytokines and chemokines from PMN and monocytes. This review focuses on the interaction of MTB and the host with regard to activation of the innate immune response. It also attempts to identify the potential impact of this early response on the subsequent pathogenesis of MTB, and its role in development and extent of tuberculosis. Insights into the initiation and persistent of the inflammatory response may allow the application of anti-inflammatory agents as adjuncts in the treatment of tuberculosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abou-Zeid C., Ratliff T. L., Wiker H. G., Harboe M., Bennedsen J. and Rock G. A. W. (1988): Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovin BCG. Infect. Immun., 56, 3046–3047.
Actor J. K., Olsen M., Jagannath C. and Hunter R. L. (1999): Relationship of survival, organism containment, and acute murine tuberculosis. J. Interferon Cytokine Res., 19, 1183–1193.
Aung H., Toossi Z., Wisnieski J. J., Culp L. A., Phillips N. B., Averill L. E., Daniel T. M. and Ellner J. J. (1996): Induction expression of tumor necrosis factor alpha by the 30 kDa alpha anti- gen of Mycobacaterium tuberculosis synergism with fibronectin. J. Clin. Invest., 98, 1261–1268.
Barnes P. F., Chatterjee D., Abrams J. S., Lu S., Want E., Yamamura M., Brennan P. J. and Modin R. L. (1992): Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J. Immunol., 149, 541–547.
Barnes P. F., Lu S., Abrams J. S., Wang E., Yamamure M. and Modlin R. L. (1993): Cytokine production at the site of the disease in human tuberculosis. Infect. Immun., 61, 3482–3489.
Bogdan C., Paik J., Vodovotz Y. and Nathan C. (1992): Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor f3 and interleukin-10. J. Biol. Chem., 267, 2301–2308.
Boom W. H. (1999): Gammadelta T cells and Mycobacterium tuberculosis. Microbes Infect., 1, 187–195.
Byrd T. F. (1997): Tumor necrosis factor (TNF) promotes growth of Mycobacterium tuberculosis in human monocytes. Iron-mediated growth suppression is correlated with decreased release of TNF. J. Clin. Invest., 99, 2528–2529.
Casatella A. M. (1999): Neutrophil-derived proteins: Selling cytokines by the pound. Adv. Immunol., 73, 369–494.
Chan J. and Kaufman H. E. (1994): Immune mechanisms of protection. In Bloom A. S. M. (ed.): Tuberculosis: pathogenesis, protection and control. Washington, DC, 389–415.
Dahl K. E., Shiratsuchi H., Hamilton B. D., Ellner J. J. and Toossi Z. (1996): Selective induction of TGF-f3 in human monocytes by lipoarabinomannan of M. tuberculosis. Infect. Immun., 64, 399–405.
Ding A., Nathan C. and Srimal S. (1990): Macrophage deactivating factor and TGF-f3 inhibit macrophage nitrogen oxide synthesis by IFN gamma. Immunology, 145, 940–945.
Ehlers S., Benini J., Kutsch S., Endres R., Rietschel E. T. and Pfeffer K. (1999): Fatal granuloma necrosis without exacerbated mycobaterial growth in tumor necrosis factor receptor gene deficient mice intravenously infected with Mycobacterium avium. Infect. Immun., 67, 3571–3579.
Ellner J. J. (1997): The human response in tuberculosis. J. Infect. Dis., 176, 1351–1359.
Fenhalls G., Wong A., Bezuidenhout J., van Helden P., Bardin P. and Lukey P. T. (2000): In situ production of gamma interleukin-4 and tumor necrosis factor alpha mRNA in human lung tuberculosis granulomas. Infect. Immun., 68 2827–2836.
Fenton M. J., Vermeulen M. W., Kim S., Burdick M., Strieter R. M. and Kornfeld H. (1997): Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun., 65, 5149–5156.
Flynn J. L. Goldstein M. M., Chan J., Triebold K. J., Pfeffer K., Lowenstein C. J., Schreiber R., Mak T. W. and Bloom B. R. (1995): Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 2 561–572.
Fratazzi C., Arbeit R. D., Carini C., Balcewicz-Sablinska M. K., Keane J., Kornfeld H. and Remold H. G. (1999): Macrohpage apoptosis in mycobacterial infections. J. Leukoc. Biol., 66, 763–764.
Fulton S. A., Martin T. D., Redline R. W. and Boom W. H. (2000): Pulmonary immune responses during primary Myco Calmette-Guerin bacillus infection in C57B16 mice. Am. J. Respir. Cell Mol. Biol., 22, 333–343.
Fulton S. A., Johnsen J. M., Wolf S. F., Sieberth D. S. and Boom W. H. (1996): Interleukin-12 production by human infected with Mycobacterium tuberculosis: role of phagocytosis. Infect. Immun., 64, 25–23.
Garrait V., Cadranel J., Esvant H., Herry I., Morinet E, Mayaud C. and Israel-Biet D. (1997): Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J. Immunol., 159, 2824–2830.
Hirsch C. S., Ellner J. J., Russell D. G. and Rich E. A. (1994a): Complement receptor-mediated uptake and tumor necrosis a-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol., 152, 743–749.
Hirsch C. S., Toossi Z., Othieno C., Johnson J. L., Schwander S. K., Robertson S., Wallis R.S., Edmonds K. A., Mugerwa R., Peters P. and Ellner J. J. (1999): Depressed T-cell interferon--gamma responses in pulmonary tuberculosis analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis., 180, 2069–2073.
Hirsch C. S., Yoneda T., Ellner J. J., Averill L. E. and Toossi Z. (1994b): Enhancement of intracellular growth of M. tuberculosis in human monocytes by transforming growth factor beta. J. Infect. Dis., 170, 1229–1237.
Howard A. D. and Zwilling B. S. (1998): Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice. Clin. Exp. Immunol., 113, 443–449.
Hunter S. W., Gaylord B. E. and Brennan P. J. (1986): Structure and antigenicity of the phosophorylated lipopolysa antigens from the leprosy and tubercle bacilli. J. Biol. Chem., 261, 12345–12351.
Huygen K., Van Vooren J. P., Turneer M., Bosmans R., Dierckx P. and DeBruyn J. (1988): Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand. J. Immunol., 27, 187–194.
Jacobs M., Brown N., Allie N. and Ryffel B. (2000): Fatal Mycobacterium bovis BCG infection in TNF LT-alpha-deficient mice. Chest, 117, 103–109.
Kasahara K., Sato I., Ogura K., Takeuchi H., Kobayashi K. and Adachi M. (1998): Expression of chemokines and rapid cell death in human blood neutrophils by M. tuberculosis. J. Infect. Dis., 178, 127–137.
Kasahari V. M., Chen Y. Q., Su M. W., Ramirez F. and Uitto J. (1990): Tumor necrosis factor a and interferon y suppress the activation of human type I collagen gene expression by transforming growth factor 3 1. J. Clin. Invest., 86, 1489–1494.
Kemp K., Hviid L., Kharazmi A. and Kemp M. (1997): Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major. Scand. J. Immunol., 46, 495–499.
Kim S. J., Angel P., Lafyatis R. and Roberts A. B. (1990): Autoinduction of transforming growth factor 31 is mediated by the AP-1 complex. Mol. Cell Biol., 10, 1492–1495.
Kindler V., Sappino A. P, Grau G. E., Piguer P. F. and Vassalli P. (1989): The inducing role of tumor necrosis factor in the development of bacterial granulomas during BCG infection. Cell, 56, 731–740.
Lawn S. D., Shattock R. J., Acheampong J. W., Lal R. B., Folks T. M., Griffin G. E. and Butera S. T. (1999): Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parame- ters of immune activation during treatment of tuberculosis in Africans. AIDS, 13, 2231–2237.
Lin Y., Zhang H., Gong J. and Barnes P. F. (1996): Absence of a prominent TH2 cytokine response in human tuberculosis. Infect. Immun., 64, 1351–1356.
May M. and Spagnuolo P J. (1987): Evidence for activation of the respiratory burst in the interaction of human neutrophils with M. tuberculosis. Infect. Immun., 55, 2304–2307.
Mustafa T., Phyu S., Nilsen R., Jonsson R. and Bjune G. (2000): In situ expression of cytokine and cellular phenotypes in mice with slowly progressive primary tuberculosis. Scand. J. Immunol., 51, 548–556.
Muthuswamy P, Hu Y. C., Carasso B., Antonio M. and Dandamudi N. (1995): Prednisone as adjunctive therapy in the management of pulmonary tuberculosis report of 12 cases and review of the literature. Chest, 107, 1621–1630.
North R. J. (1995): M. tuberculosis strikingly more virulent for mice when given via the respiratory than via the intravenous route. J. Infect. Dis., 172, 1550–1553.
Oppenheim J. J., Zacharie C. O. C., Mokaida N. and Matsamushima K. (1991): Properties of the novel pro-infiamma “intercine” cytokine family. Annu. Rev. Immunol., 9 617–648.
Orme I. M. and Cooper A. M. (1999): Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today, 20, 307–312.
Othieno C., Hirsch C. S., Hamilton B. D., Wilkinson K., Ellner J. J. and Toossi Z. (1999): Interaction of M. tuberculosis-induced transforming growth factor [31 and interleukin 10. Infect. Immun., 67, 5730–5735.
Rhoades E. R., Frank A. A. and Orme I. M. (1997): Progresion of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis., 78, 57–66.
Rich E. A., Torres M., Sada E., Finegan C. K., Hamilton B. D. and Toossi Z. (1997): Mycobacterium tuberculosis-stimulated expression of inducible nitric oxide synthase and production of nitric oxide by human alveolar macrophages. Tuber. Lung Dis., 78, 247–255.
Riedel D. D. and Kaufmann S. H. (1997): Chemokine secretion by human polymorphonuclear granulocytes after stimulation with M. tuberculosis and lipoarabinomannan. Infect. Immun., 65, 4620–4523.
Rollins B. J. (1997): Chemokines. Blood, 90, 909–928.
Rook G. A. W. and Hernandez-Pando R. (1996): The pathogenesis of tuberculosis. Annu. Rev. Microbiol., 50, 259–284.
Sadek M. I., Sada E., Toossi Z., Schwander S. K. and Rich E. A. (1997): Chemokines induced by infection of mono phagocytes with M. tuberculosis and in the lungs during active pulmonary tuberculosis. Tuber. Lung Dis., 78, 247–255.
Schwander S. K., Sada E., Torres M., Escobedo D., Sierra J. G. and Alt Rich E. A. (1996): T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J. Infect. Dis., 173, 1267–1272.
Schwander S. K., Torres M., Carranza C., Escobedo D., Tary-Lehmann M., Anderson P., Toossi Z., Ellner J. J., Rich E. A. and Sada E. (2000): Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J. Immunol., 165, 1479–1485.
Senderovitz T. and Viskum K. (1994): Corticosteroids and tuberculosis. Res. Med., 88, 561–569.
Silver R. F., Li Q and Ellner J. J. (1998): Expression of virulence of Mycobacerium tuberculosis with human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun., 66, 1190–1199.
Smith D. W., Wiegeshaus E. H., Navalkar R. and Grover A. A. (1966): Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and non-vaccinated animals. J. Bacteriol., 91, 718–724.
Snider D. E., Raviglione M. and Kochi A. (1994): Global burden of tuberculosis. In Bloom A. S. M. (ed.): Tuberculosis: pathogenesis, protection and control. Washington DC, 3–11.
Solis-Herruzo J. A., Brenner D. A. and Chojkier M. (1998): Tumor necrosis factor a inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J. Biol. Chem., 163, 5841–5847.
Sporn M. B., Roberts A. M., Wakefield L. M. and Assoian R. K. (1986): Transforming growth factor 13 biological function and chemical structure. Science, 233, 532–535.
Tavares J. L., Wangoo A., Dilworth P., Marshall B., Kotecha S. and Shaw R. J. (1997): Thalidomide reduces tumor necrosis factor a alpha production by human alveolar macrophages. Respir. Med., 91, 31–39.
Toossi Z. (1996): Cytokine circuits in tuberculosis. Infect. Agents Dis., 5, 98–107.
Toossi Z., Gogate P., Shiratsuchi H., Young T. and Ellner J. J. (1995): Enhanced production of transforming growth factor 3 (TGF13) by blood monocytes from patients with active tuberculosis and presence of TGF13 in tuberculosis granulomatous lung lesions. J. Immunol., 154, 465–473.
Toossi Z., Hirsch C. S., Hamilton B. D., Knuth C. K., Friedlander M. A. and Rich E. A. (1996): Decreased production of transforming growth factor 131 (TGFf31) in human alveolar macrophages. J. Immunol., 156, 3461–3468.
Toossi Z., Xia L. and Salvekar A. (1999): Transcriptional activities of human immunodeficiency virus (HIV) by Mycobacterium tuberculosis in human monocytes. Clin. Exp. Immunol., 117, 324–330.
Torres M., Herrera T., Villareal H. and Sada E. (1998): Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to 30 kD antigen of Mycobacterium tuberculosis. Infect. Immun., 66, 176–180.
Tramontana J. M., Utaipat U., Molly A., Akarasewi P., Burroughs M., Makonkawkeypoon S., Johnson B., Klausner J. D., Rom W. and Kaplan G. (1995): Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol. Med., 1, 384–397.
Tsao T. C., Hong J., Huang C., Yang P., Liao S. K. and Chang K. S. (1999): Increased TNF-alpha, IL-1 beta and IL-6 levels in bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients active pulmonary tuberculosis. Tuber. Lung Dis., 79, 279–285.
Valone S. E., Rich E. A., Wallis R. S. and Ellner J. J. (1988): Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect. Immun., 56, 3313–3333.
Vanham G., Edmonds K. E., Qing L., Hom D., Toossi Z., Joness B., Daley C., Huebner R., Kestens L., Gigase P. and Ellner J. J. (1996): Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin. Exp. Immunol., 103, 30–34.
Vicenzi E., Biswas P., Mengozzi M. and Poli G. (1997): Role of pro-inflammatory cytokines and 13-chemokines in controlling HIV replication. J. Leukoc. Biol., 62, 34–40.
Wahl S. M., Allen J. B., Weeks B. S., Wong H. L. and Klotman P. E. (1993): Transforming growth factor (3 enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA, 90, 4577–4581.
Wallis R. S., Fujiwara H. and Ellner J. J. (1996a): Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J. Immunol., 136, 193–196.
Wallis C. C., Nsubuga R, Whalen C. C., Mugerwa R. D., Okwera A., Oette D., Jackson J. L., Johnson J. J. and Ellner J. J. (1996b): Pentoxifylline therapy in human immunodeficiency virus-serpositive persons with tuberculosis: a randomized controlled trial. J. Infect. Dis., 174, 727–733.
Wallis R. S., Paranjape R. and Phillips M. (1993): Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis. Infect. Immun., 61, 627–632.
Whalen C., Horsburgh C. R., Hom D., Lahart C., Simberkoff M. and Ellner J. J. (1995): Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med., 151, 129–135.
Zabel A. and Ulrich Schade F. (1993): Inhibition of endogenous TNF formation by Pentoxifylline. Immunobiology, 187, 447–463.
Zhang Y., Broser M., Cohen H., Bodkin M., Law K., Reibman J. and Rom W. N. (1995): Enhanced interleukin and gene expression in macrophage after exposure to Mycobacterium tuberculosis and its comp. J. Clin. Invest., 95, 586–592.
Zhu W., Downey J. S., Gu J., Di Padova F., Gram H. and Han J. (2000): Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J. Immunol., 164, 6349–6358.
Zugmaier G., Paik S., Wilding G., Knabbe C., Bano M., Lupu R., Deschauer B., Simpson S., Dickson R. B. and Lippman M. (1991): Transforming growth factor 13 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res., 51, 3590–3594.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Toossi, Z. (2001). The Inflammatory Response in Mycobacterium Tuberculosis Infection. In: Górski, A., Krotkiewski, H., Zimecki, M. (eds) Inflammation. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9702-9_11
Download citation
DOI: https://doi.org/10.1007/978-94-015-9702-9_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5852-2
Online ISBN: 978-94-015-9702-9
eBook Packages: Springer Book Archive